Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An open-label trial of donepezil in vascular and mixed dementia.

Trial Profile

An open-label trial of donepezil in vascular and mixed dementia.

Phase of Trial: Phase III

Latest Information Update: 26 Mar 2015

At a glance

  • Drugs Donepezil (Primary)
  • Indications Dementia; Vascular dementia
  • Focus Therapeutic Use
  • Acronyms Vaspect
  • Sponsors Pfizer
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 12 Nov 2008 Status changed from completed to discontinued, as reported in ClinicalTrials.Gov record. The trial was terminated on 15 Oct 2007 citing recruitment difficulties and emphasising no safety or efficacy concerns regarding the study medication.
    • 25 Sep 2008 Actual patient number (149) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top